Work

An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes (HES)

Year: 2021

Type: article

Study design: Observational Study

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2020.12.505

Authors: Michael Chen, Praveen Akuthota, Timothy Lax, Sameer Mathur, Princess Ogbogu, Thanai Pongdee, Marc Rothenberg, Florence Roufosse, Dagmar Simon, Miguel Stein, Sa Wang, Michael Wechsler, Amy Klion, Bruce Bochner

Institutions: Northwestern University, University of California San Diego, Beth Israel Deaconess Medical Center, University of Wisconsin–Madison, The Ohio State University Wexner Medical Center, Mayo Clinic, Cincinnati Children's Hospital Medical Center, Université Libre de Bruxelles, Erasmus Hospital, University of Bern, University Hospital of Bern, Tel Aviv University, Wolfson Medical Center, The University of Texas MD Anderson Cancer Center, National Jewish Health, National Institutes of Health

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3127568940

FWCI:

Cites:

Cited by:

Related to: 10